Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.jcin.2018.10.039 | DOI Listing |
Eur Heart J Case Rep
May 2024
Department of Cardiology, University Hospital of Leon, Altos de Nava s/n, 24008, Leon, Spain.
Background: Percutaneous closure of aortic-to-right ventricle (ARV) fistula has emerged as an alternative to surgical management in selected cases. The use of three-dimensional (3D) printing in interventional planning for structural heart disease provides a concrete understanding, and it is useful in diagnostic assessment and to guide treatment approaches and to simulate procedures.
Case Summary: We report a case of a 70-year-old male presenting in cardiogenic shock due to severe aortic stenosis and reduced left ventricular ejection fraction.
Eur Heart J Case Rep
March 2022
Department of Cardiology, Royal Brompton & Harefield Hospitals, Guy's and St Thomas' NHS Foundation Trust, Hill End Rd, Harefield, Uxbridge UB9 6JH, UK.
Background: Aortic-to-right ventricle (ARV) fistula is an uncommon complication of transcatheter aortic valve implantation (TAVI). Even though surgical closure is usually the treatment of choice in such communications, percutaneous treatment options are valuable alternatives for these high-risk surgical patients.
Case Summary: In this article, we present the percutaneous closure of an ARV fistula after TAVI, in a highly symptomatic patient with recurrent episodes of heart failure decompensation with worsening right ventricular function, who failed conservative medical treatment and was deemed inoperable.
Echocardiography
February 2022
Department of Cardiology, SBU Diyarbakır Gazi Yaşargil Education and Research Hospital, Diyarbakır, Turkey.
Transthoracic and transesophageal imaging of a 30-year-old patient who presented with palpitations and shortness of breath revealed flow from the aorta to the right atrium. An aortic-right atrial fistula, which is a rare anomaly, was evaluated. As there was no acquired cause, it was considered a congenital defect.
View Article and Find Full Text PDFJACC Cardiovasc Interv
January 2019
Division of Cardiology, American University of Beirut Medical Center, Beirut, Lebanon. Electronic address:
Am J Cardiol
December 2005
Department of Internal Medicine, Baylor University Medical Center, Dallas, Texas, USA.
The percutaneous closure of atrial septal defects is increasingly used. Serious complications of the procedure, such as cardiac perforation and tamponade, are rare and usually occur <72 hours after device placement. The investigators report the late development of the erosion of an Amplatzer septal occluder into the ascending aorta with associated aortic-to-right atrial fistula formation.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!